Table 3

Results of non-parametric bootstrapping and sensitivity analysis

Characteristics

Per 100 Patients screened


% Not Asthmatic

28

2.5% Credible Interval

19

97.5% Credible Interval

37

% Not Asthmatic and on Daily Medication

20

2.5% Credible Interval

13

97.5% Credible Interval

28

Average Cost Savings

$35,141

2.5% Credible Interval

$4,588

97.5% Credible Interval

$69,278

*Average cost saving per patient screened is $ 351

Sensitivity Analysis

25 year time horizon

Average Cost Savings

$24,390

2.5% Credible Interval

$1,181

97.5% Credible Interval

$47,600

*Average cost saving per patient screened is $ 243

GP consult rather than specialist

Average Cost Savings

$45,016

2.5% Credible Interval

$14,463

97.5% Credible Interval

$79,153

*Average cost saving per patient screened is $ 450

As needed 1 to 2 puffs of short-acting bronchodilator per week

Average Cost Savings

$29,798

2.5% Credible Interval

-$3,396

97.5% Credible Interval

$102,307

*Average cost saving per patient screened is $ 298

As needed 4 to 8 puffs of short-acting bronchodilator per week

Average Cost Savings

$41,606

2.5% Credible Interval

$474

97.5% Credible Interval

$113,843

*Average cost saving per patient screened is $ 416


Pakhale et al. BMC Pulmonary Medicine 2011 11:27   doi:10.1186/1471-2466-11-27

Open Data